Project Number 3R44AG056166-02S1 Agency/Funding Organization NIA Funding Year 2017 View Full Project Details for Additional bioanalytical, dose analysis and DSMB costs for PTI-125 development Research Categorization Primary Disease / Condition Alzheimer's Disease CADRO Category C. Translational Research and Clinical Interventions 7. Early-stage Clinical Drug Development (Phase I and II Clinical Trials) a. Amyloid beta Researcher and Organization Principal Investigator BURNS, LINDSAY H. Principal Investigator First Name LINDSAY H. Principal Investigator Last Name BURNS Awardee Organization PAIN THERAPEUTICS, INC. Awardee State Texas Contact PI Country United States Project Detail Funding Opportunity Announcement PA-16-287: Administrative Supplements to Existing NIH Grants and Cooperative Agreements (Admin Supp) FY Overall Cost $141,748 Funding Organization Agency/Funding Organization NIA Funding Organization Country United States Program Official REFOLO, LORENZO